DJIA 16,880.36 -31.75 -0.19%
NASDAQ 4,462.90 20.20 0.45%
S&P 500 1,970.07 0.12 0.01%
market minute promo

ACTAVIS (NYSE: ACT)

215.55 0.70 (0.33%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ACT $215.55 0.33%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $215.61
Previous Close $214.85
Daily Range $214.75 - $216.56
52-Week Range $130.06 - $230.77
Market Cap $37.6B
P/E Ratio -54.67
Dividend (Yield) $0.00 (0.0%)
Volume 1,565,517
Average Daily Volume 2,336,691
Current FY EPS $13.67

Sector

Healthcare

Industry

Drugs

ACTAVIS (ACT) Description

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products. Website: http://www.actavis.com/

News & Commentary Rss Feed

Is This Drug Maker’s Stock Too Cheap to Ignore?

Teva Pharmaceutical shares have under performed its sector over the past year. Though the company faces a number of issues, most of the bad news may already be priced into the stock. Given the drug maker also appears to have some intriguing opportunities for future growth, are Teva shares too cheap to ignore?

Tax Inversion Puts These 3 Mutual Funds in Focus - Best of Funds

Tax Inversion Puts These 3 Mutual Funds in Focus - Best of Funds

UPDATE: Bank Of America Reiterates On Actavis plc On Strong Strategic/Financial Position

Diamond Hill Capital Comments on Actavis PLC

Diamond Hill Capital Comments on Actavis PLC

Activis Shares Languish Post-Forest Deal

George Soros Reveals His Largest Stake

Wednesday's ETF with Unusual Volume: PPH

Medicines360 And Actavis Announce FDA Acceptance For Filing Of NDA For Levosertâ„¢ IUD

Synergy Pharmaceuticals Progresses with Mid-Stage Candidate - Analyst Blog

Interesting ACT Put And Call Options For December 20th

See More ACT News...

ACT's Top Competitors

ACT $215.55 (0.33%)
Current stock: ACT
JNJ $102.30 (0.33%)
Current stock: JNJ
NVS $88.44 (0.26%)
Current stock: NVS
RHHBY $36.83 (0.75%)
Current stock: RHHBY